Publications

Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.

Franke, MF; KHAN, P; Hewison, C; Khan, U; Huerga, H; Seung, KJ; Rich, ML; Zarli, K; Samieva, N; Oyewusi, L; Nair, P; Mudassar, M; Melikyan, N; Lenggogeni, P; Lecca, L; Kumsa, A; Khan, M; Islam, S; Hussein, K; Docteur, W; Chumburidze, N; Berikova, E; Atshemyan, H; Atwood, S; Alam, M; ... Mitnick, CD.

2021

American Journal of Respiratory and Critical Care Medicine, (2021).203 1 10.1164/rccm.202001-0135oc.

Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.

KHAN, MS; REGO, S; Rajal, JB; Bond, V; Fatima, RK; Isani, AK; SUTHERLAND, J; KRANZER, K;

2021

PLoS One, (2021).16 2 10.1371/journal.pone.0244936.

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa.

Ntshiqa, T; Chihota, V; Mansukhani, R; Nhlangulela, L; Velen, K; Charalambous, S; Maenetje, P; Hawn, TR; Wallis, R; GRANT, AD; Fielding, K; Churchyard, G;

2021

Gates Open Research, (2021).5, 10.12688/gatesopenres.13191.1.

'We had to manage what we had on hand, in whatever way we could': adaptive responses in policy for decentralized drug-resistant tuberculosis care in South Africa.

Kielmann, K; Dickson-Hall, L; Jassat, W; Le Roux, S; Moshabela, M; Cox, H; GRANT, AD; Loveday, M; Hill, J; Nicol, MP; Mlisana, K; Black, J;

2021

Health policy and planning (2021). 10.1093/heapol/czaa147.

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.

Penn-Nicholson, A; Mbandi, SK; Thompson, E; Mendelsohn, SC; Suliman, S; Chegou, NN; Malherbe, ST; Darboe, F; Erasmus, M; Hanekom, WA; Bilek, N; Fisher, M; Kaufmann, SH E; Winter, J; Murphy, M; Wood, R; Morrow, C; Van Rhijn, I; Moody, B; Murray, M; Andrade, BB; Sterling, TR; SUTHERLAND, J; Naidoo, K; Padayatchi, N; ... CAPRISA IMPRESS team,

2020

Scientific reports, (2020).10 1 10.1038/s41598-020-65043-8.

Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.

TOGUN, T; KAMPMANN, B; Stoker, NG; Lipman, M;

2020

Annals of clinical microbiology and antimicrobials, (2020).19 1 10.1186/s12941-020-00363-1.

Prevalence and Risk Factors for Mycobacterium tuberculosis Infection Among Adolescents in Rural South Africa.

Mzembe, T; Lessells, R; Karat, AS; Randera-Rees, S; Edwards, A; KHAN, P; Tomita, A; Tanser, F; BAISLEY, K; GRANT, AD;

2020

Open Forum Infectious Diseases, (2020).8 1 10.1093/ofid/ofaa520.

The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis.

MCQUAID, CF; HORTON, KC; Dean, AS; KNIGHT, GM; WHITE, RG;

2020

The European respiratory journal, (2020).56 3 10.1183/13993003.00626-2020.

Effects of vitamin D deficiency on neurobehavioural outcomes in children: a systematic review.

Mutua, AM; Mogire, RM; ELLIOTT, AM; Williams, TN; WEBB, EL; Abubakar, A; Atkinson, SH;

2020

Wellcome open research, (2020).5, 10.12688/wellcomeopenres.15730.2.

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda.

Lubyayi, L; Mawa, PA; Nabakooza, G; Nakibuule, M; Tushabe, JV; Serubanja, J; Aibo, D; Akurut, H; Tumusiime, J; Hasso-Agopsowicz, M; KALEEBU, P; Levin, J; DOCKRELL, HM; Smith, S; WEBB, EL; ELLIOTT, AM; COSE, S;

2020

FRONTIERS IN IMMUNOLOGY, (2020).11, 10.3389/fimmu.2020.00929.